OWKIN

Overview

Owkin is a French-American AI biotechnology company founded in 2016 by Thomas Clozel and Gilles Wainrib. The company focuses on using artificial intelligence and machine learning to enhance drug discovery, development, and diagnostics, particularly in precision medicine and oncology.

The mission is to improve patient outcomes by identifying new drug candidates, accelerating clinical trials, and creating AI-powered diagnostic tools. Their proprietary platform, OWKIN Socrates, utilizes federated learning to analyze diverse patient data from multiple institutions while maintaining data privacy. Collaborating with pharmaceutical companies and research institutions, Owkin is recognized as a leader in AI-driven drug development and cancer research innovation with significant funding raised.

Basic Information

Industry	information technology & services
Founded	2016
Revenue	125.4M
Headquarters	831 Broadway, New York, NY 10003, United States
Languages	English
Alexa Ranking	N/A

Contact Details

Key Focus Areas & Initiatives

Artificial intelligence for drug discovery and development
Precision medicine and oncology
AI-powered diagnostic tools
Federated learning for clinical data privacy
Multi-omics data analysis and research
Clinical trial optimization
Collaboration with pharmaceutical companies
MOSAIC multi-omics atlas initiative
AI-driven biomarker discovery and validation
Digital pathology workflows
Predictive analytics in medicine
AI for disease progression and treatment monitoring
Patient stratification models
Healthcare analytics

Technologies Used

Adobe Media Optimizer
Amazon AWS
Amazon SES
Cedexis Radar
CloudFlare Hosting
Cloudflare DNS
DNSimple
DoubleClick
DoubleClick Conversion
Gmail
Google Apps
Google Dynamic Remarketing
Google Font API
Google Tag Manager
Greenhouse.io
Hotjar
JQuery 1.11.1
Kubernetes
MailChimp SPF
Microsoft Office 365
Mobile Friendly
Netlify
Outlook
React
Remote
Salesforce
Vimeo
WP Engine
Webflow
Zendesk

OWKIN | Company Profile